Reliq Health Technologies - CEO Dr. Lisa Crossley.
CEO Dr. Lisa Crossley.
Source: Reliq Health Technologies
  • Reliq Health Technologies (RHT) has signed contracts with five new US clients
  • These five new contracts will add over 2,000 new Medicare patients to the company’s iUGO Care platform
  • Concerns over the Omicron variant this winter means clinicians will be even more motivated to keep their high-risk patients at home
  • Reliq’s iUGO Care platform helps protect chronic disease patients by allowing them to receive high quality healthcare in their own homes
  • Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring
  • Reliq Health Technologies Inc. (RHT) opened trading at C$1.13 per share

Reliq Health Technologies (RHT) has signed contracts with five new US clients, including three physician practices, a home health agency and a hospice provider.

“We are pleased to be adding three primary care practices, a home health agency and a hospice care provider as new clients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.

“As the Omicron variant raises new concerns about COVID transmission this winter, clinicians are even more motivated to keep their high-risk patients healthy and at home. Reliq’s iUGO Care platform helps protect chronic disease patients by allowing them to receive high quality healthcare in their own homes, avoiding the potential exposure to COVID and flu viruses in clinic and hospital settings. These five new contracts will add over 2,000 new Medicare patients to our platform in Q1 calendar year 2022 at an average revenue of over $50 USD per patient per month. Onboarding will begin in the new year.”

Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.

Reliq Health Technologies Inc. (RHT) opened trading at C$1.13 per share.

More From The Market Online

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

New government funding coming for Canada’s first commercial space port

Maritime Launch Services (NEO:MAXQ) announces a pivotal step forward in the development of Canada’s first commercial orbital spaceport.